PackTalk is a blog for the Healthcare Packaging Industry

Cold Chain Packaging: Packaging Engineers Wanted


Published on July 26, 2021

COVID-19 has put a public spotlight on the economic global demands and challenges related to cold chain drug supply and delivery. And while the growth trends in the world of cold chain packaging are not new, the focus is certainly heightened, leading to demands in product monitoring and packaging standardization, as well as stricter regulatory requirements. Temperature controlled pharmaceuticals are growing at twice the rate of the overall industry. According to supply chain research in the pharmaceutical space, global spend in the pharmaceutical cold chain segment is expected to grow 24% between 2020 and 2024, with approximately 25% of that spend dedicated to packaging.  

So, what should those of us tied to the world of healthcare packaging be considering when partnering to develop products and packaging that will meet the needs of the cold chain environment? Adept Packaging recently published a white paper on this very subject, concentrating on the importance of applying a holistic approach to the full development and commercialization process. The publication is worth reading in its entirety, but here are some key takeaways specifically related to packaging development: 

The Package is the Product 

The age-old challenge for Packaging Engineers and Designers has been ensuring package design is considered at the start of product development. But one could argue that this is even more imperative when developing temperature sensitive products. Temperature affects both the product AND the package, and common packaging processes—such as sealing and sterilization—will have a significant impact on temperatures experienced throughout manufacturing. Recognizing the package as part of the overall product provides an opportunity to explore the most effective and efficient solutions from the start and makes it easier to involve manufacturing and logistic partners early on as well. Will the finished good be preconditioned? Where will it ship to, and by what means? Will the packaging design meet the needs to maintain continuous or active temperature controls? These are all questions integral to both the product and the package at the design stage.  

Regulatory Companion – Avoid Downstream Rework 

It is all too common to involve Regulatory partners late in the product development process, which could lead to significant downstream rework if regulatory submissions cannot achieve approval. This is especially risky in the pharmaceutical cold chain industry, where regulatory requirements are getting more stringent, but with less benchmarking available. Partnering with Regulatory early will help define requirements related to product and packaging materials and substances—particularly the usage of potentially hazardous materials such as dry ice or liquid nitrogen—stability testing, distribution testing for various temperatures and regions, and monitoring systems. 

The pharmaceutical cold chain packaging industry growth and related increase in business value provides product development teams with the opportunity and need to employ the technical and liaison skills of Packaging Engineers upstream. This approach will prevent downstream rework, mitigate patient safety and business-related risks, and aid in creating processes that can streamline future development. It’s an exciting challenge with the potential for immense positive impact to companies that recognize and implement the right approach at the right time! 

Haley Schrauben
Product Manager | Oliver Healthcare Packaging

Comments (0)

Related Articles

One Doctor’s Request for Sustainable Change in Asia

September 17, 2021

152 kilograms. 4500 tonnes. 134 hectares. No matter how you say it, it’s not positive or sustainable. These numbers reflect the amount of medical waste from just one surgery, in a study from four hospitals over three months in New Zealand. 152 kilograms is...

Learn More

Cracking the Age Old Dilemma: Compliance or Quality?

September 17, 2021

I recently read an article from Medtech Insights on how device giants Stryker and Baxter embrace a quality first culture – and yield positive results. In the article, Stryker’s Medha Trivedi, the company’s senior director of global quality and operations said...

Learn More

Power to the PDUFA

September 17, 2021

The Prescription Drug User Fee Act was passed into law by Congress in 1992. The PDUFA implemented a fee-based framework for New Drug Applications and Biologics License Applications. One of its primary objectives was to provide funding to speed up the glacial...

Learn More

Stay Informed

To stay up to date on innovative technology and products, as well as industry trends, subscribe to Oliver’s PackTalk blog below.